| Autor: |
Sanjay Basu, MD, David Flood, MD, Pascal Geldsetzer, MD, Michaela Theilmann, MA, Maja E Marcus, MA, Cara Ebert, PhD, Mary Mayige, MBChB, Roy Wong-McClure, MD, Farshad Farzadfar, MD, Sahar Saeedi Moghaddam, MS, Kokou Agoudavi, MD, Bolormaa Norov, MSc, Corine Houehanou, PhD, Glennis Andall-Brereton, PhD, Mongal Gurung, PhD, Garry Brian, MD, Pascal Bovet, MD, Joao Martins, PhD, Rifat Atun, ProfFRCP, Till Bärnighausen, ProfMD, Sebastian Vollmer, ProfPhD, Jen Manne-Goehler, MD, Justine Davies, ProfMD |
| Jazyk: |
angličtina |
| Rok vydání: |
2021 |
| Předmět: |
|
| Zdroj: |
The Lancet Global Health, Vol 9, Iss 11, Pp e1539-e1552 (2021) |
| Druh dokumentu: |
article |
| ISSN: |
2214-109X |
| DOI: |
10.1016/S2214-109X(21)00340-5 |
| Popis: |
Summary: Background: Given the increasing prevalence of diabetes in low-income and middle-income countries (LMICs), we aimed to estimate the health and cost implications of achieving different targets for diagnosis, treatment, and control of diabetes and its associated cardiovascular risk factors among LMICs. Methods: We constructed a microsimulation model to estimate disability-adjusted life-years (DALYs) lost and health-care costs of diagnosis, treatment, and control of blood pressure, dyslipidaemia, and glycaemia among people with diabetes in LMICs. We used individual participant data—specifically from the subset of people who were defined as having any type of diabetes by WHO standards—from nationally representative, cross-sectional surveys (2006–18) spanning 15 world regions to estimate the baseline 10-year risk of atherosclerotic cardiovascular disease (defined as fatal and non-fatal myocardial infarction and stroke), heart failure (ejection fraction of |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
